세프트리아손(CAS 번호: 73384-59-5)

세프트리아손(CAS 번호: 73384-59-5)


Ceftriaxone is a broad-spectrum, third-generation cephalosporin antibiotic widely used in clinical settings. Known for its long half-life and powerful efficacy against Gram-positive and Gram-negative bacteria, it is especially effective in treating severe and systemic infections. The compound is administered via injection and is a critical choice in hospitals and emergency care.

애플리케이션

Ceftriaxone is commonly prescribed for treating a wide range of infections, including:

Lower respiratory tract infections (e.g., pneumonia)

Urinary tract infections

Intra-abdominal infections

Skin and soft tissue infections

Meningitis

Septicemia

Gonorrhea

Its strong resistance to β-lactamase enzymes makes it highly effective in handling antibiotic-resistant bacteria, including Haemophilus influenzae and Neisseria gonorrhoeae.

 

Contraindications

Ceftriaxone is contraindicated in patients with:

Known hypersensitivity to cephalosporins

Neonates with hyperbilirubinemia

Concurrent use with calcium-containing IV solutions in neonates (risk of fatal precipitate formation)

Caution is also advised in patients with renal or hepatic impairment.


Usage and Administration

Ceftriaxone is typically administered by intravenous (IV) or intramuscular (IM) injection. Dosage depends on the infection type, patient age, and overall health condition. Common adult doses range from 1 to 2 grams once daily, or in divided doses for more severe infections. The treatment duration usually spans from 4 to 14 days, based on clinical response.

 

Other Advantages
Once-daily dosing increases patient compliance

Minimal renal excretion, making it suitable for patients with renal dysfunction

Strong penetration into cerebrospinal fluid, ideal for treating central nervous system infections

 

견적 요청

제품에 대한 완벽한 통제를 통해 고객에게 최상의 품질, 가격 및 서비스를 제공할 수 있습니다.

drug discovery and development company

당사의 제품에 관심이 있으시면 여기에 정보를 남겨주세요. 빠른 시일 내에 연락드리겠습니다.